Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Rhode Island Industrial Facilities Corporation (RIIFC) is a quasi-public state agency and public body corporate established by the Rhode Island General Assembly in 1967. The corporation's primary mission is to foster economic growth and industrial development within Rhode Island by providing low-cost financing solutions to private sector entities. RIIFC is authorized to issue tax-exempt and taxable revenue bonds, construction loan notes, and equipment acquisition notes to fund the acquisition, construction, and equipping of industrial and commercial facilities. While not a life sciences company itself, RIIFC plays a significant role in the sector by acting as a conduit issuer for bonds that finance specialized manufacturing plants and research facilities for biotechnology and healthcare companies. In many cases, RIIFC technically holds title to these facilities as part of the financing arrangement, providing additional benefits such as sales tax exemptions on construction materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rhode Island Industrial Facilities.